Peripheral-Specific y2 receptor knockdown protects mice from high-fat diet-induced obesity

Obesity

Volumn 19, Issue 11, 2011, Pages 2137-2148

  Shi, Yan Chuan ^a   Lin, Shu ^a   Castillo, Lesley ^a   Aljanova, Aygul ^a   Enriquez, Ronaldo F ^a   Nguyen, Amy D ^a   Baldock, Paul A ^a   Zhang, Lei ^a   Bijker, Martijn S ^a   MacIa, Laurence ^a   Yulyaningsih, Ernie ^a   Zhang, Hui ^a   Lau, Jackie ^a   Sainsbury, Amanda ^a,b   Rzog, Herbert ^a,b  

^a GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROPEPTIDE Y2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MASS; CONTROLLED STUDY; ENERGY EXPENDITURE; FOOD INTAKE; GLUCOSE TOLERANCE; HYPERALGESIA; LEAN BODY WEIGHT; LIPID DIET; LUNG GAS EXCHANGE; MALE; MOUSE; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; SIGNAL TRANSDUCTION; WEIGHT GAIN;

ADIPOSE TISSUE; ANIMALS; BODY COMPOSITION; BODY WEIGHT; BONE AND BONES; DIET, HIGH-FAT; ENERGY INTAKE; ENERGY METABOLISM; GENE KNOCKDOWN TECHNIQUES; GLUCOSE INTOLERANCE; HYPERPHAGIA; MALE; MICE; MODELS, ANIMAL; MOTOR ACTIVITY; OBESITY; RECEPTORS, NEUROPEPTIDE Y; RNA; SIGNAL TRANSDUCTION;

MUS;

EID: 80055049096     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2011.99     Document Type: Article

References (39)

1. Stanley BG, Anderson KC, Grayson MH, Leibowitz SF. Repeated hypothalamic stimulation with neuropeptide Y increases daily carbohydrate and fat intake and body weight gain in female rats. Physiol Behav 1989;46:173-177. (Pubitemid 19244074)
2. Kotz CM, Briggs JE, Grace MK, Levine AS, Billington CJ. Divergence of the feeding and thermogenic pathways influenced by NPY in the hypothalamic PVN of the rat. Am J Physiol 1998;275:R471-R477.
3. Clark SJ, Ellis N, Styne DM et al. Hormone ontogeny in the ovine fetus. XVII. Demonstration of pulsatile luteinizing hormone secretion by the fetal pituitary gland. Endocrinology 1984;115:1774-1779. (Pubitemid 15206593)
4. Stanley BG, Leibowitz SF. Neuropeptide Y: stimulation of feeding and drinking by injection into the paraventricular nucleus. Life Sci 1984;35: 2635-2642. (Pubitemid 15221101)
5. Sainsbury A, Rohner-Jeanrenaud F, Cusin I et al. Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo- pituitaryadrenal axis, and vagal mediation of hyperinsulinaemia. Diabetologia 1997;40:1269-1277. (Pubitemid 27469666)
6. Zarjevski N, Cusin I, Vettor R, Rohner-Jeanrenaud F, Jeanrenaud B. Intracerebroventricular administration of neuropeptide Y to normal rats has divergent effects on glucose utilization by adipose tissue and skeletal muscle. Diabetes 1994;43:764-769. (Pubitemid 24166351)
7. Pierroz DD, Catzeflis C, Aebi AC, Rivier JE, Aubert ML. Chronic administration of neuropeptide Y into the lateral ventricle inhibits both the pituitary-testicular axis and growth hormone and insulin-like growth factor I secretion in intact adult male rats. Endocrinology 1996;137:3-12.
8. Catzeflis C, Pierroz DD, Rohner-Jeanrenaud F et al. Neuropeptide Y administered chronically into the lateral ventricle profoundly inhibits both the gonadotropic and the somatotropic axis in intact adult female rats. Endocrinology 1993;132:224-234. (Pubitemid 23019506)
9. Billington CJ, Briggs JE, Harker S, Grace M, Levine AS. Neuropeptide Y in hypothalamic paraventricular nucleus: a center coordinating energy metabolism. Am J Physiol 1994;266:R1765-R1770.
10. Sainsbury A, Cusin I, Rohner-Jeanrenaud F, Jeanrenaud B. Adrenalectomy prevents the obesity syndrome produced by chronic central neuropeptide Y infusion in normal rats. Diabetes 1997;46:209-214. (Pubitemid 27272253)
11. Lin S, Boey D, Herzog H. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 2004;38:189-200. (Pubitemid 39161911)
12. Sainsbury A, Schwarzer C, Couzens M, Herzog H. Y2 receptor deletion attenuates the type 2 diabetic syndrome of ob/ob mice. Diabetes 2002;51:3420-3427. (Pubitemid 35403445)
13. Broberger C, Landry M, Wong H, Walsh JN, Hökfelt T. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in proopiomelanocortin-and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus. Neuroendocrinology 1997;66:393-408. (Pubitemid 27500899)
14. Sainsbury A, Bergen HT, Boey D et al. Y2Y4 receptor double knockout protects against obesity due to a high-fat diet or Y1 receptor deficiency in mice. Diabetes 2006;55:19-26. (Pubitemid 43343295)
15. Playford RJ, Cox HM. Peptide YY and neuropeptide Y: two peptides intimately involved in electrolyte homeostasis. Trends Pharmacol Sci 1996;17:436-438. (Pubitemid 27028473)
16. Zhang L, Macia L, Turner N et al. Peripheral neuropeptide Y Y1 receptors regulate lipid oxidation and fat accretion. Int J Obes (Lond) 2010;34: 357-373.
17. Kuo LE, Kitlinska JB, Tilan JU et al. Neuropeptide Y acts directly in the periphery on fat tissue and mediates stress-induced obesity and metabolic syndrome. Nat Med 2007;13:803-811. (Pubitemid 47038195)
18. Baldock PA, Sainsbury A, Couzens M et al. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 2002;109:915-921. (Pubitemid 34275112)
19. Shi YC, Lin S, Wong IP et al. NPY neuron-specific Y2 receptors regulate adipose tissue and trabecular bone but not cortical bone homeostasis in mice. PLoS ONE 2010;5:e11361.
20. Lee NJ, Doyle KL, Sainsbury A et al. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res 2010;25:1736-1747.
21. Sainsbury A, Schwarzer C, Couzens M et al. Important role of hypothalamic Y2 receptors in body weight regulation revealed in conditional knockout mice. Proc Natl Acad Sci USA 2002;99:8938-8943. (Pubitemid 34693662)
22. Kühn R, Schwenk F, Aguet M, Rajewsky K. Inducible gene targeting in mice. Science 1995;269:1427-1429.
23. Ferrannini E. The theoretical bases of indirect calorimetry: a review. Metabolism 1988;37:287-301. (Pubitemid 18080935)
24. Frayn KN. Calculation of substrate oxidation rates in vivo from gaseous exchange. J Appl Physiol 1983;55:628-634. (Pubitemid 13044099)
25. McLean JA, Tobin G. Animal and Human Calorimetry. Cambridge University Press: Cambridge,1987, pp 352.
26. Jackerott M, Larsson LI. Immunocytochemical localization of the NPY/PYY Y1 receptor in the developing pancreas. Endocrinology 1997;138: 5013-5018. (Pubitemid 27460942)
27. DeFronzo RA. Insulin resistance, lipotoxicity, type 2 diabetes and atherosclerosis: the missing links. The Claude Bernard Lecture 2009. Diabetologia, 2010;53:1270-1287.
28. Baldock PA, Allison S, McDonald MM et al. Hypothalamic regulation of cortical bone mass: opposing activity of Y2 receptor and leptin pathways. J Bone Miner Res 2006;21:1600-1607. (Pubitemid 44484605)
29. Lundberg P, Allison SJ, Lee NJ et al. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 2007;282:19082-19091. (Pubitemid 47100173)
30. Donnelly JE, Blair SN, Jakicic JM et al.; American College of Sports Medicine. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2009;41:459-471.
31. Zurlo F, Lillioja S, Esposito-Del Puente A et al. Low ratio of fat to carbohydrate oxidation as predictor of weight gain: study of 24-h RQ. Am J Physiol 1990;259:E650-E657. (Pubitemid 20385711)
32. MacLean PS, Higgins JA, Wyatt HR et al. Regular exercise attenuates the metabolic drive to regain weight after long-term weight loss. Am J Physiol Regul Integr Comp Physiol 2009;297:R793-R802.
33. Zhang L,Riepler SJ, Turner N et al. Y2 and Y4 receptor signalling synergistically act on energy expenditure and physical activity. Am J Physiol Regul Integr Comp Physiol 2010;299:R1618-R1628.
34. Broqua P, Wettstein JG, Rocher MN, Gauthier-Martin B, Junien JL. Behavioral effects of neuropeptide Y receptor agonists in the elevated plus-maze and fear-potentiated startle procedures. Behav Pharmacol 1995;6:215-222.
35. Kalra SP, Kalra PS. NPY and cohorts in regulating appetite, obesity and metabolic syndrome: beneficial effects of gene therapy. Neuropeptides 2004;38:201-211. (Pubitemid 39158859)
36. Rossignol S, Chau C, Brustein E et al. Pharmacological activation and modulation of the central pattern generator for locomotion in the cat. Ann N Y Acad Sci 1998;860:346-359. (Pubitemid 29045982)
37. Masaki T, Chiba S, Noguchi H et al. Obesity in insulin receptor substrate-2-deficient mice: disrupted control of arcuate nucleus neuropeptides. Obes Res 2004;12:878-885. (Pubitemid 41127325)
38. Scheen AJ. The endocannabinoid system: a promising target for the management of type 2 diabetes. Curr Protein Pept Sci 2009;10:56-74.
39. Tasan RO, Nguyen NK, Weger S et al. The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 2010;30:6282-6290.